For biotech founders, advisors and BD teams
The investor database every biotech raise starts with
900+ verified US biotech VCs with direct partner emails, investment focus, check sizes and deal stage.
Delivered as Excel + CSV. Filter by stage, focus or check size, then export the emails.
Each VC profile includes
Direct partner emailsNo gatekeepers, no contact forms
Investment focusTherapeutics, MedTech, Digital Health, Diagnostics and more
Typical check sizeFrom $250K to $10M+
Deal stageSeed, Series A, B and beyond
Pick your sector
See exactly what you get
Real rows from the database. Filter by sector, stage and location, then export the partner emails.
| Firm | Sectors | Stages | Location | Partner emails |
|---|---|---|---|---|
| Flagship Pioneeringflagshippioneering.com | TherapeuticsBiotechnologyLife Sciences IT/AI+2 | Seed – Series C | Cambridge, MA | 10 emails |
| ARCH Venture Partnersarchventure.com | TherapeuticsBiotechnologyDigital Health+2 | Seed – Series A | Chicago, IL | 9 emails |
| Third Rock Venturesthirdrockventures.com | TherapeuticsMedTech | Pre-seed – Series A | Boston, MA | 9 emails |
| OrbiMedorbimed.com | TherapeuticsMedTechDiagnostics+3 | Seed – Series E | New York, NY | 9 emails |
| New Enterprise Associatesnea.com | TherapeuticsMedTechDiagnostics+3 | Pre-seed – Series E | Menlo Park, CA | 9 emails |
| Atlas Ventureatlasventure.com | TherapeuticsBiotechnology | Seed – Series A | Cambridge, MA | 10 emails |
| 5AM Ventures5amventures.com | TherapeuticsDiagnosticsMedTech+1 | Seed – Series C | San Francisco, CA | 9 emails |
| RA Capital Managementracap.com | TherapeuticsDiagnosticsBiotechnology+2 | Pre-seed – Series E | Boston, MA | 10 emails |
| Versant Venturesversantventures.com | TherapeuticsBiotechnologyMedTech | Series A – Series C | San Francisco, CA | 9 emails |
| Venrockvenrock.com | TherapeuticsDiagnosticsBiotechnology+3 | Seed – Series C | Palo Alto, CA | 10 emails |
FAQ
Questions before you buy
Biotech-only focus, with no noise from unrelated industries. Deep investor profiles that include funding criteria and even the scientific milestones each investor prioritizes.
It saves you 100+ hours by replacing guesswork with a ready-to-pitch list, pre-filtered by stage, therapy area and capital needs. You avoid mismatches by knowing which VCs are actively deploying capital in your niche, and you can shape each pitch around investor priorities.
Biotech founders raising Seed to Series C rounds, business development teams at life sciences startups, and consultants building investor pipelines for clients.
You receive an Excel file to browse and filter investors by stage, investment focus or ticket size, then export the emails from the CSV file for instant outreach. No technical skills required.







